BioSpace News Archive

DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare research, services and solutions to federal agencies, today announced that it has been awarded a follow-on contract to provide medical logistics to the Department of Veterans Affairs (“VA”) Consolidated Mail Outpatient Pharmacy (“CMOP”).

NeoRhythm is already a big hit. Launched by one of the most successful campaigns in the history of Indiegogo, and with over 8000 happy users and counting, this wellness wearable is going from strength to strength

Recommendation based on positive results from the Phase 3 CheckMate -743 trial, in which Opdivo plus Yervoy demonstrated significantly superior overall survival vs. standard-of-care chemotherapy

Flavors & Extracts Group and the Asia Pacific Group Report Strong Revenue and Profit Growth Personal Care Continues to be Negatively Impacted by the COVID-19 Pandemic In April, the Company Completed the Divestiture of Fragrances

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, will present data at the American Academy of Dermatology’s Virtual Meeting Experience, being held April 23 – 25, 2021.

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced the appointment of David Wheadon, M.D., to its Board of Directors.

Key insights for payers and providers about the use of telerehabilitation services during COVID-19 were highlighted in the latest research from Focus on Therapeutic Outcomes (FOTO), a Net Health company. The findings were published online ahead of print in the American Physical Therapy Association’s (APTA) Physical Therapy Journal.

AbbVie (NYSE: ABBV) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for VENCLYXTO® (venetoclax) in combination with hypomethylating agents for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy.

Revance Therapeutics, a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that it will present four ePoster abstracts at the virtual American Academy of Dermatology (AAD VMX) meeting, April 23-25,

Spacelabs Healthcare, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS), announced today that it has been awarded a three-year Premier agreement for physiological patient monitoring and non-invasive cardiology solutions.